MY184693A - Bilayer hydrocolloid films containing therapeutic agents - Google Patents

Bilayer hydrocolloid films containing therapeutic agents

Info

Publication number
MY184693A
MY184693A MYPI2013701483A MYPI2013701483A MY184693A MY 184693 A MY184693 A MY 184693A MY PI2013701483 A MYPI2013701483 A MY PI2013701483A MY PI2013701483 A MYPI2013701483 A MY PI2013701483A MY 184693 A MY184693 A MY 184693A
Authority
MY
Malaysia
Prior art keywords
bilayer
therapeutic agents
films containing
containing therapeutic
hydrocolloid
Prior art date
Application number
MYPI2013701483A
Inventor
Fern Ng Shiow
Ei Thu Hnin
Original Assignee
Univ Kebangsaan Malaysia Ukm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kebangsaan Malaysia Ukm filed Critical Univ Kebangsaan Malaysia Ukm
Priority to MYPI2013701483A priority Critical patent/MY184693A/en
Priority to PCT/MY2014/000222 priority patent/WO2015026225A1/en
Publication of MY184693A publication Critical patent/MY184693A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention provides a bilayer hydrocolloid pharmaceutical film, suitable for use as slow-release dressing, containing a lower layer comprising glycerol, water-based solvents and a hydrogel-forming polymer, and a upper layer comprising glycerol, water-based solvents, a hydrogel-forming polymer and a therapeutic agent. The invention further includes a method of preparation of the pharmaceutical film and its use as mucosa surface dressing.
MYPI2013701483A 2013-08-22 2013-08-22 Bilayer hydrocolloid films containing therapeutic agents MY184693A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MYPI2013701483A MY184693A (en) 2013-08-22 2013-08-22 Bilayer hydrocolloid films containing therapeutic agents
PCT/MY2014/000222 WO2015026225A1 (en) 2013-08-22 2014-08-20 Bilayer hydrocolloid films containing therapeutic agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2013701483A MY184693A (en) 2013-08-22 2013-08-22 Bilayer hydrocolloid films containing therapeutic agents

Publications (1)

Publication Number Publication Date
MY184693A true MY184693A (en) 2021-04-17

Family

ID=52483934

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2013701483A MY184693A (en) 2013-08-22 2013-08-22 Bilayer hydrocolloid films containing therapeutic agents

Country Status (2)

Country Link
MY (1) MY184693A (en)
WO (1) WO2015026225A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015130891A2 (en) 2014-02-26 2015-09-03 Illumicure Inc. Ultraviolet phototherapy apparatuses and methods
JP2019511343A (en) 2016-02-09 2019-04-25 ルマ セラピューティクス，インク．Ｌｕｍａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． Methods, compositions and devices for treating psoriasis with phototherapy
CN106267357B (en) * 2016-08-09 2019-08-06 上海交通大学 It is a kind of to repair the two-layer compound hydrogel of osteochondral tissue, preparation method and application
CN115124738B (en) * 2022-07-11 2023-03-17 西南交通大学 Double-layer bionic drug-loaded hydrogel and preparation and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536263A (en) * 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
DE19925519A1 (en) * 1999-06-04 2000-12-07 Lohmann Therapie Syst Lts Laminar wound dressing for controlled release of active substance e.g. platelet derived growth factor, includes layer containing polymer and hydrogel as fluid absorber
DE602004025824D1 (en) * 2003-09-08 2010-04-15 Fmc Biopolymer As GEL FOAM ON BIOPOLYMER BASE
DE202011108805U1 (en) * 2011-09-02 2012-09-03 BLüCHER GMBH wound dressing
CN202682163U (en) * 2012-06-08 2013-01-23 稳健实业(深圳)有限公司 Double-layer hydrocolloid medical dressing

Also Published As

Publication number Publication date
WO2015026225A1 (en) 2015-02-26

Similar Documents

Publication Publication Date Title
EP3081597A4 (en) Fluorine-containing ether composition, method for producing same, coating liquid, base material having surface treatment layer, and method for producing same
EP3210604A4 (en) Uses of duloxetine hcl medicament in preparing pharmaceutical composition for treatment of cancer
SG194155A1 (en) Multilayer thin film drug delivery device and methods of making and using the same
GB201411465D0 (en) Active pharmaceutical ingredient (api) comprising cannabinoids for use in the treatment of cancer
IL232308A (en) C0mpounds as modulators of atp-binding cassette transporters, pharmaceutical compositions comprising them and their use in the preparation of medicaments for treating diseases and processes for preparation thereof
MX366230B (en) Multi-polymer compositions for transdermal drug delivery.
WO2015160975A3 (en) Combination of a pi3k inhibitor with a bcl-2 inhibitor for use in the treatment of cancer
IN2015DN01165A (en)
IN2015DN01164A (en)
EP3399963A4 (en) Gel compositions for transdermal delivery to maximize drug concentrations in the stratum corneum and serum and methods of use thereof
EA201591830A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING EVEROLIMUS
MX2016011744A (en) Sustained-release buprenorphine solutions.
PH12018502738A1 (en) Compositions, devices, and methods for the treatment of alcohol use disorder
MX2015008021A (en) Compositions and methods for transdermal delivery of hormones and other medicinal agents.
IL250510A0 (en) Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof
HUE060093T2 (en) Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
EP3398605A4 (en) Medicinal composition for improving prognosis after restart of patient's own heartbeat
WO2016001905A3 (en) Stable liquid ready-to-use injectable formulation of bortezomib
EP3052125A4 (en) Composition and method for therapeutic agent delivery during pregnancy
EP3337482A4 (en) Transdermal formulations for delivery of berberine compounds, and their use in the treatment of berberine-responsive diseases and conditions
MY184693A (en) Bilayer hydrocolloid films containing therapeutic agents
CL2014001959A1 (en) Compounds derived from substituted phenyl-1h-imidazo [1,2-b] pyrazole; preparation procedure; pharmaceutical composition; and use in the treatment of cancer.
MX2013004693A (en) Aripiprazole compositions and methods for its transdermal delivery.
EP2963125A4 (en) Method for assaying microrna, cancer therapeutic agent, and medicinal composition containing same for cancer therapy
EP3213760A4 (en) Soluble, stable, anti-inflammatory, proliferative, protective and mucoadhesive pharmaceutical compositions; use thereof for treating mucositis conditions and method for producing same; base pharmaceutical composition for preparing the pharmaceutical compositions and method for producing same